Speeding up access to new drugs for CF: Considerations for clinical trial design and delivery
Authors:
- Jane C DaviesJDJane C Davies
- Pavel DrevinekPDPavel Drevinek
- European Cf Society (Ecfs) Strategic Planning Task Force On ‘Speeding Up Access To New 4 Drugs For Cf’ECEuropean Cf Society (Ecfs) Strategic Planning Task Force On ‘Speeding Up Access To New 4 Drugs For Cf’
- Margarida D AmaralMAMargarida D Amaral
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 18 (5) , 677-684
Abstract
No abstract availableKeywords
Funding Information
- Vertex Pharmaceuticals
- European Medicines Agency
- Cystic Fibrosis Foundation
This publication has 30 references indexed in Scilit:
- Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulationJournal of Cystic Fibrosis, 2015
- Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutationJournal of Cystic Fibrosis, 2014
- Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With IvacaftorClinical Infectious Diseases, 2014
- Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D- CFTR mutation and preserved spirometry: a randomised controlled trialThe Lancet Respiratory Medicine, 2013
- Evaluation and use of childhood lung function tests in cystic fibrosisCurrent Opinion in Pulmonary Medicine, 2012
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationThorax, 2011
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutationNew England Journal of Medicine, 2010
- Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosisPediatric Pulmonology, 2010
- Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary ExacerbationAmerican Journal of Respiratory and Critical Care Medicine, 2010